Chipotle Mexican Grill (NYSE:CMG – Free Report) had its price target cut by Stifel Nicolaus from $70.00 to $68.00 in a ...

Stifel Nicolaus analyst Tore Svanberg maintained a Buy rating on Power Integrations (POWI – Research Report) today and set a price target of ...

In a report released today, Shlomo Rosenbaum from Stifel Nicolaus maintained a Buy rating on Equifax (EFX – Research Report), with a price ...

Bill Stern, a partner in Goodwin Procter’s financial services practice, said the “pendulum” of regulation is due to swing ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Proficient Auto Logistics (NASDAQ:PAL – Get Free Report) had its price target decreased by investment analysts at Stifel Nicolaus from $15.00 to $14.00 in a report released on Thursday ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...

Jefferies LLC and Stifel, Nicolaus & Company, Incorporated served as financial advisors to ImaginAb on the transaction. About ImaginAb, Inc. ImaginAb, Inc. is a clinical stage, revenue-generating ...